Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...
A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...
Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA™ abuse deterrent transdermal technology ...
Nutriband’s AVERSA™ abuse-deterrent technology can be utilized to incorporate aversive agents into transdermal patches to deter abuse, including oral abuse, of any drug with a risk of abuse, misuse, ...
Patients and prescribers alike are familiar with the vast array of psychiatric medicines available to treat mental illnesses. They are often less aware that certain psychotropics can be delivered via ...
AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback